» Articles » PMID: 24428591

Is Polypharmacy Always Hazardous? A Retrospective Cohort Analysis Using Linked Electronic Health Records from Primary and Secondary Care

Overview
Specialty Pharmacology
Date 2014 Jan 17
PMID 24428591
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Prescribing multiple medications is associated with various adverse outcomes, and polypharmacy is commonly considered suggestive of poor prescribing. Polypharmacy might thus be associated with unplanned hospitalization. We sought to test this assumption.

Methods: Scottish primary care data for 180 815 adults with long-term clinical conditions and numbers of regular medications were linked to national hospital admissions data for the following year. Using logistic regression (age, gender and deprivation adjusted), we modelled the association of prescribing with unplanned admission for patients with different numbers of long-term conditions.

Results: Admissions were more common in patients on multiple medications, but admission risk varied with the number of conditions. For patients with one condition, the odds ratio for unplanned admission for four to six medications was 1.25 (95% confidence interval 1.11-1.42) vs. one to three medications, and 3.42 (95% confidence interval 2.72-4.28) for ≥10 medications vs. one to three medications. However, this effect was greatly reduced for patients with multiple conditions; amongst patients with six or more conditions, those on four to six medications were no more likely to have unplanned admissions than those taking one to three medications (odds ratio 1.00; 95% confidence interval 0.88-1.14), and those taking ≥10 medications had a modestly increased risk of admission (odds ratio 1.50; 95% confidence interval 1.31-1.71).

Conclusions: Unplanned hospitalization is strongly associated with the number of regular medications. However, the effect is reduced in patients with multiple conditions, in whom only the most extreme levels of polypharmacy are associated with increased admissions. Assumptions that polypharmacy is always hazardous and represents poor care should be tempered by clinical assessment of the conditions for which those drugs are being prescribed.

Citing Articles

Diabetes in Peripheral Artery Disease: Prevalence, Complications, and Polypharmacy.

Baty M, Chimoriya R, James S, Kritharides L, Behdasht S, Suryawanshi A J Clin Med. 2025; 14(4).

PMID: 40004919 PMC: 11856835. DOI: 10.3390/jcm14041383.


Methods for identifying adverse drug reactions in primary care: A systematic review.

Logan V, Hughes D, Turner A, Carter N, Jordan S PLoS One. 2025; 20(2):e0317660.

PMID: 39903764 PMC: 11793789. DOI: 10.1371/journal.pone.0317660.


The impact of polypharmacy on health outcomes in the aged: A retrospective cohort study.

Boateng I, Pascual C, Grassby P, Asghar Z, Ibrahim K PLoS One. 2025; 20(2):e0317907.

PMID: 39899651 PMC: 11790100. DOI: 10.1371/journal.pone.0317907.


Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial.

Gillespie P, Moriarty F, Smith S, Hobbins A, Walsh S, Clyne B Eur J Health Econ. 2024; .

PMID: 39190222 DOI: 10.1007/s10198-024-01718-7.


Protocol for the development and validation of a Polypharmacy Assessment Score.

Tsang J, Sperrin M, Blakeman T, Payne R, Ashcroft D Diagn Progn Res. 2024; 8(1):10.

PMID: 39010248 PMC: 11251249. DOI: 10.1186/s41512-024-00171-7.


References
1.
Leendertse A, Egberts A, Stoker L, Van den Bemt P . Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008; 168(17):1890-6. DOI: 10.1001/archinternmed.2008.3. View

2.
Barnett K, Mercer S, Norbury M, Watt G, Wyke S, Guthrie B . Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012; 380(9836):37-43. DOI: 10.1016/S0140-6736(12)60240-2. View

3.
Diederichs C, Berger K, Bartels D . The measurement of multiple chronic diseases--a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci. 2010; 66(3):301-11. DOI: 10.1093/gerona/glq208. View

4.
Lau D, Kasper J, Potter D, Lyles A, Bennett R . Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005; 165(1):68-74. DOI: 10.1001/archinte.165.1.68. View

5.
Jyrkka J, Enlund H, Korhonen M, Sulkava R, Hartikainen S . Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging. 2009; 26(12):1039-48. DOI: 10.2165/11319530-000000000-00000. View